Found: 105
Select item for more details and to access through your institution.
Inhibition of O6‐methylguanine‐DNA‐methyltransferase (MGMT) by lomeguatrib reduces multiple myeloma cell viability and impairs DNA repair in MGMT‐proficient cells.
- Published in:
- Chemical Biology & Drug Design, 2024, v. 103, n. 2, p. 1, doi. 10.1111/cbdd.14465
- By:
- Publication type:
- Article
HIV‐1 integrase inhibitor raltegravir promotes DNA damage‐induced apoptosis in multiple myeloma.
- Published in:
- Chemical Biology & Drug Design, 2023, v. 102, n. 2, p. 262, doi. 10.1111/cbdd.14237
- By:
- Publication type:
- Article
Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft verses host disease.
- Published in:
- Pathology & Oncology Research, 1999, v. 5, n. 3, p. 229, doi. 10.1053/paor.1999.0229
- By:
- Publication type:
- Article
Ex vivo expansion of natural killer cells for hematological cancer immunotherapy: a systematic review and meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2503, doi. 10.1007/s10238-022-00923-z
- By:
- Publication type:
- Article
Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 931, doi. 10.1111/bjh.19271
- By:
- Publication type:
- Article
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338
- By:
- Publication type:
- Article
Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 561, doi. 10.1111/bjh.17321
- By:
- Publication type:
- Article
Prognostic scoring system after transplantation in myeloma: predicting early relapse.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. 323, doi. 10.1111/bjh.16986
- By:
- Publication type:
- Article
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 66, doi. 10.1111/bjh.14821
- By:
- Publication type:
- Article
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 896, doi. 10.1111/bjh.14787
- By:
- Publication type:
- Article
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 1, p. 61, doi. 10.1111/bjh.14637
- By:
- Publication type:
- Article
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 783, doi. 10.1111/bjh.14483
- By:
- Publication type:
- Article
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1172, doi. 10.1177/10781552221103551
- By:
- Publication type:
- Article
Stem cell mobilizating effect of heparin in patients undergoing autologous stem cell transplantation.
- Published in:
- Journal of Clinical Apheresis, 2023, v. 38, n. 6, p. 685, doi. 10.1002/jca.22079
- By:
- Publication type:
- Article
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
- By:
- Publication type:
- Article
Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 481, doi. 10.1002/ajh.26480
- By:
- Publication type:
- Article
Impact of “Killer Immunoglobulin-Like Receptor /Ligand” Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132526
- By:
- Publication type:
- Article
Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 6, p. 1027, doi. 10.1007/s00277-018-3274-0
- By:
- Publication type:
- Article
Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 4, p. 577, doi. 10.1007/s00277-011-1349-2
- By:
- Publication type:
- Article
Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease.
- Published in:
- Wiener Klinische Wochenschrift, 2013, v. 125, n. 15/16, p. 439, doi. 10.1007/s00508-013-0385-4
- By:
- Publication type:
- Article
Manual Versus Automated Volume Reduction of Cord Blood.
- Published in:
- European Journal of Therapeutics, 2022, v. 28, n. 2, p. 102, doi. 10.54614/eurjther.2021.0029
- By:
- Publication type:
- Article
Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3940, doi. 10.3390/jcm10173940
- By:
- Publication type:
- Article
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 73, doi. 10.1111/ejh.13706
- By:
- Publication type:
- Article
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
- Published in:
- 1999
- By:
- Publication type:
- commentary
Familial Multiple Myeloma Associated with Disorders of Chronic Inflammation: First Report from Turkey.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 4, p. 246
- By:
- Publication type:
- Article
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01380-0
- By:
- Publication type:
- Article
Vitiligo after Hematopoietic Cell Transplantation: Six Cases and Review of the Literature.
- Published in:
- Dermatology (10188665), 2008, v. 216, n. 4, p. 349, doi. 10.1159/000117705
- By:
- Publication type:
- Article
Factors influencing the success of cord blood collection: a tertiary perinatal medicine center's experience.
- Published in:
- Turkish Journal of Medical Sciences, 2018, v. 48, n. 5, p. 961, doi. 10.3906/sag-1802-54
- By:
- Publication type:
- Article
Akut Myeloid Lösemi Tanısı ile Akraba Dışı Vericiden Allojeneik Hematopoietik Kök Hücre Nakli Yapılan Hastalarda ATG Kullanımının Nakil Sonuçlarına Etkisi.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2021, v. 74, n. 3, p. 337, doi. 10.4274/atfm.galenos.2021.95866
- By:
- Publication type:
- Article
Trombositozlu Olgularda Terapötik Trombosit Aferezinin Etkinliği.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2021, v. 74, n. 3, p. 278, doi. 10.4274/atfm.galenos.2021.08860
- By:
- Publication type:
- Article
Myelodisplastik Sendromda Allojeneik Kök Hücre Nakli.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2020, v. 73, n. 2, p. 113, doi. 10.4274/atfm.galenos.2020.65365
- By:
- Publication type:
- Article
Myelodisplastik Sendromda Allojeneik Kök Hücre Nakli.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2020, v. 73, n. 2, p. 113, doi. 10.4274/atfm.galenos.2020.65365
- By:
- Publication type:
- Article
Tüylü Hücreli Lösemide Tedavi Yaklaşımımız.
- Published in:
- Journal of Ankara University Faculty of Medicine / Ankara Üniversitesi Tip Fakültesi Mecmuasi, 2020, v. 73, n. 1, p. 5, doi. 10.4274/atfm.galenos.2020.50570
- By:
- Publication type:
- Article
Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.800711
- By:
- Publication type:
- Article
Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Drug Targeting of Genomic Instability in Multiple Myeloma.
- Published in:
- Frontiers in Genetics, 2020, p. 1, doi. 10.3389/fgene.2020.00228
- By:
- Publication type:
- Article
Hyperkeratosis of the Nipple Associated with Chronic Graft versus Host Disease after Allogeneic Haematopoietic Cell Transplantation.
- Published in:
- Acta Dermato-Venereologica, 2003, v. 83, n. 5, p. 385, doi. 10.1080/00015550310012665
- By:
- Publication type:
- Article
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation.
- Published in:
- European Journal of Haematology, 2015, v. 95, n. 4, p. 316, doi. 10.1111/ejh.12491
- By:
- Publication type:
- Article
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 1, p. 16, doi. 10.1111/j.1600-0609.2010.01524.x
- By:
- Publication type:
- Article
Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment.
- Published in:
- 2000
- By:
- Publication type:
- journal article
A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity.
- Published in:
- Immunogenetics, 2021, v. 73, n. 6, p. 449, doi. 10.1007/s00251-021-01227-4
- By:
- Publication type:
- Article
Donor-recipient killer immunoglobulin like receptor (KIR) gene-gene matching improves post-transplant outcomes in HLA identical sibling hematopoietic cell transplantation: matching reduces frequency of relapse and graft versus host disease.
- Published in:
- Turkish Journal of Immunology, 2016, v. 4, p. 22
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center.
- Published in:
- Balkan Medical Journal, 2023, v. 40, n. 3, p. 197, doi. 10.4274/balkanmedj.galenos.2023.2022-2-32
- By:
- Publication type:
- Article
Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data.
- Published in:
- Balkan Medical Journal, 2023, v. 40, n. 1, p. 51, doi. 10.4274/balkanmedj.galenos.2022.2022-2-48
- By:
- Publication type:
- Article
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 165, doi. 10.1016/j.clml.2023.10.009
- By:
- Publication type:
- Article
A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 394, doi. 10.1016/j.clml.2023.02.007
- By:
- Publication type:
- Article
Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma: A Retrospective Single-center Experience on Efficacy, Safety and Survival Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e164, doi. 10.1016/j.clml.2022.12.007
- By:
- Publication type:
- Article
Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 596, doi. 10.1016/j.clml.2022.02.007
- By:
- Publication type:
- Article